BI
Bioqual, Inc.
BIOQ · OTC
$33.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $29.5M
P/E Ratio -
Div. Yield -
ROE 3.46%
Bulios Fair Price
$32.36
1.9% downside
Current Price
$33
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BIOQ is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
64 /100
Fair P/S 0.70x
P/B 0.84x
P/FCF 4.97x
Growth
4 /100
Declining Book val. growth 1.36%
Rev. growth 9.60%
FCF growth N/A
Profitability
25 /100
Weak Net margin 2.92%
Op. margin 5.40%
FCF margin 14.02%
Quality
7 /100
Poor ROE 3.46%
ROA 1.72%
Asset turnover 0.59x
Debt
39 /100
Moderate Current ratio 4.01x
Net debt/EBITDA 16.45x
Debt/Equity 0.96x
Stability
43 /100
Moderate Rev. volatility 6.21%
EPS volatility 147.94%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIOQ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Hanne Andersen-Elyard
Employees
278
Headquarters
Rockville